Mutations of the VHL gene in sporadic renal cell carcinoma: Definition of a risk factor for VHL patients to develop an RCC

Human Mutation

Volumn 13, Issue 6, 1999, Pages 464-475

  Gallou, C ^a   Joly, D ^a   Mejean A ^a   Staroz, F ^a   Martin, N ^a   Tarlet, G ^a   Orfanelli, M T ^a   Bouvier, R ^b   Droz, D ^a   Chretien Y ^a   Marechal J M ^b   Richard, S ^a   Junien, C ^a   Beroud C ^a,c  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c HÔPITAL BROUSSAIS   (France)

Author keywords

Database; Mutations; Renal cell carcinoma; VHL gene; Von Hippel Lindau

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; DATA BASE; DISEASE PREDISPOSITION; GENE EXPRESSION; GENE MUTATION; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MISSENSE MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

EID: 0032970571     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1004(1999)13:6<464::AID-HUMU6>3.0.CO;2-A     Document Type: Article

References (40)

1. Bailly M, Bain C, Favrot M, Ozturk M. 1995. Somatic mutations of von Hippel-Lindau (VHL) tumor-suppressor gene in European kidney cancers. Int J Cancer 63:660-664.
2. Béroud C, Soussi T. 1996. APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 24:121-124.
3. Béroud C, Fournet J-C, Jeanpierre C, Froger D, Droz D, Chrétien Y, Bouvier R, Maréchal JM, Couturier J, Weissenbach J, Junien C. 1996a. Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in renal cell carcinoma. Genes Chromosome Cancer 16:215-224.
4. Béroud C, Verdier F, Soussi T. 1996b. p53 gene: database of mutations in human tumors and cell lines: second edition. Nucleic Acids Res 24:147-150.
5. Béroud C, Joly D, Gallou C, Staroz F, Orfanelli MT, Junien C. 1998. Software and database for the analysis of mutations in the VHL gene. Nucleic Acids Res 26:256-258.
6. Brauch H, Kishida T, Glavac D. 1995. von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect. Hum Genet 95:551-556.
7. Chen F, Kishida T, Yao M, Hustad T, Hustad T, Glavac D, Dean D, Gnarra JR, Orcutt ML, Duh FM, Glenn GM, Green J, Hsia YE, Lamiell J, Li H, Wei MH, Schmidt L, Tory K, Kuzmin I, Stackhouse T, Latif F, Linehan WM, Lerman MI, Zbar B. 1995. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat 5:66-75.
8. Clinical Research Group for VHL in Japan. 1995. Germline mutations in the von Hippel-Lindau disease (VHL) gene in Japanese VHL. Hum Mol Genet 4:2233-2237.
9. Collod G, Béroud C, Soussi T, Junien C, Boileau C. 1996. Software and database for the analysis of mutations in the human FBN1 gene. Nucleic Acids Res 24:137-140.
10. Crossey PA, Richards FM, Foster K, Green JS, Prowse A, Latif F, Lerman MI, Zbar B, Affara NA, Ferguson-Smith MA, Maher ER. 1994. Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum Mol Genet 3:1303-1308.
11. Duan DR, Pause A, Burgess WH, Aso T, Chen DYT, Garret KP, Conaway RC, Conaway JW, Linehan WM, Klausner RD. 1995. Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 269:1402-1406.
12. Fleming S. 1993. Classification and progress of renal cell carcinoma. Pathol Res Pract 189:695-696.
13. Foster J, Prowse A, van den Berg A, Fleming S, Hulsbeek MMF, Crossey PA, Richards FM, Cairns P, Affara NA, Ferguson-Smith MA, Buys CHCM, Maher ER. 1994. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. Hum Mol Genet 3:2169-2173.
14. Glavac D, Neumann H, Wittke C, Jaenig H, Masek O, Streicher T, Pausch F, Engelhardt D, Plate K, Hofler H, Chen F, Zbar B, Brauch H. 1996. Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe. Hum Genet 98:271-280.
15. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM, Lubensky I, Duan DR, Florence C, Pozzatti R, Walther MM, Bander NH, Grossman HB, Brauch H, Pomer S, Brooks JD, Isaacs WB, Lerman MI, Zbar B, Linehan WM. 1994. Mutations of the VHL tumor suppressor gene in renal cell carcinoma. Nature Genet 7:85-89.
16. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Lue S, Samid D, Duan DSR, Gnarra JR, Linehan WM, Baylin SB. 1994. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91:9700-9704.
17. Kanno H, Kondo K, Ito S, Yamamoto I, Fujii S, Torigoe S, Sakai N, Hosaka M, Shuin T, Yao M. 1994. Somatic mutations of the Von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res 54:4845-4847.
18. Kanno H, Shuin T, Kondo K, Ito S, Hosaka M, Torigoe S, Fujii S, Tanaka Y, Yamamoto I, Kim I, Yao M. 1996. Molecular genetic diagnosis of von Hippel-Lindau disease: analysis of five Japanese families. Jpn J Cancer Res 87:423-428.
19. Kibel A, Iliopoulos O, DeCaprio JA, Kaelin WGJ. 1995. Binding of the von Hippel-Lindau tumor suppressor protein to elongin B and C. Science 269:1444-1446.
20. Kishida T, Stackhouse TM, Chen F, Lerman MI, Zbar B. 1995. Cellular proteins that bind the von Hippel-Lindau disease gene product: mapping of binding domains and the effect of missense mutations. Cancer Res 55:4544-4548.
21. Kovacs G. 1993. Molecular differential pathology of renal cell tumours. Histopathology 22:1-8.
22. Kuzmin I, Duh F-M, Latif F, Geil L, Zhar B, Lerman MI. 1995. Identification of the promoter of the human von Hippel-Lindau disease tumor suppressor gene. Oncogene 10:2185-2194.
23. La Vecchia C, Negri E, D'Avanzo B, Franceschi S. 1990. Smoking and renal cell carcinoma. Cancer Res 50:5231-5233.
24. Latif F, Tory K, Gnarra J, Yao M, Duh F-M, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou F, Li H, Chen F, Lerman M. 1993. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317-1320.
25. Maher E, Yates J. 1990. Clinical features and natural history of von Hippel-Lindau disease. QJ Med 77:1151-1163.
26. Maher E, Webster A, Richards F, Green J, Crossey P, Payne S, Moore A. 1996. Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations. J Med Genet 33:328-332.
27. Malker H, Malker B. 1984. Kidney cancer among leather workers. Lancet 1:56-57.
28. Mostofi F. 1981. Histological typing of kidney tumors. In: Mostofi FK, editor. International histological classification of tumors. Geneva: World Health Organisation.
29. Pause A, Lee S, Worrell R, Chen DYT, Burgess WH, Linehan WM, Klausner RD. 1997. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc Natl Acad Sci USA 94:2156-2161.
30. Rainwater L, Farrow G, Lieber M. 1986. Flow cytometry of renal oncocytoma: common occurrence of DNA polyploïdy and aneuploïdy. J Urol 134:1167.
31. Richard S, Olschwang S, Chauveau D, Resche F. 1995. La maladie de von Hippel-Lindau. Med Sci 11:43-51.
32. Richards FM, Payne SJ, Zbar B, Affara NA, Ferguson-Smith MA, Maher ER. 1995. Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. Hum Mol Genet 4:2139-2145.
33. Sekido Y, Bader S, Latif F, Gnarra JR, Gazdar AF, Linehan WN, Zbar B, Lerman MI, Minna JD. 1994. Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines. Oncogene 9:1599-1604.
34. Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamura H, Latif F, Zbar B, Lerman MI, Yao M. 1994. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 54:2852-2855.
35. Siemeister G, Weindel K, Mohrs K, Barleon B, Martiny-Baron G, Marmé D. 1996. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cell by von Hippel-Lindau tumor suppressor protein. Cancer Res 56:2299-2301.
36. Thoenes W, Störkel S, Rumpelt J. 1986. Histopathology and classification of renal cell tumors. Pathol Res Pract 181:125-143.
37. Tsuchiya H, Iseda T, Hino O. 1996. Identification of a novel protein (VBP1) binding to the von Hippel-Lindau (VHL) tumor suppressor gene product. Cancer Res 56:2881-2885.
38. Whaley J, Naglich J, Gelbert L, Hsia Y, Lamiell J, Green J, Collins D, Neumann H, Laidlaw J, Li F, Klein Szanto A, Seizinger B, Kley N. 1994. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet 55:1092-1102.
39. Yu M, Mack T, Hanisch R, et al. 1986. Cigarette smoking, obesity, diuretic use and coffee consumption as risk factors for renal cell carcinoma. J Natl Cancer Inst 77:351.
40. Zbar B, Kishida T, Chen F, Schmidt L, Maher E, Richards F, Crossey P, Webster A, Affara N, Ferguson-Smith M, Brauch H, Glavac D, Neumann H, Tisherman S, Mulvihill J, Gross D, Shuin T, Whaley J, Seizinger B, Kley N, Olschwang S, Boisson C, Richard S, Lips C, Marston Linehan W, Lerman M. 1996. Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe and Japan. Hum Mutat 8:348-357.